These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors.
    Author: Li Y, Wang Y, Xie N, Xu M, Qian P, Zhao Y, Li S.
    Journal: Eur J Med Chem; 2015 Jul 15; 100():270-6. PubMed ID: 26140961.
    Abstract:
    Guided by the principle of nonclassical electronic isosterism and structural optimization, a series of novel HDAC inhibitors bearing a bicyclic heterocycle moiety were designed and synthesized based on the lead compound of MS-275. All the prepared compounds were evaluated for their in vitro antiproliferative activities against HCT-116, MCF-7 and A549 human cancer cell lines, all compounds exerted excellent antitumor activities. Moreover, the compound 4a exhibited an acceptable pharmacokinetic profile with bio-availability in rat of 76% and could be considered as a candidate compound for further development.
    [Abstract] [Full Text] [Related] [New Search]